Organizations
Conferences
Info & Opinion
December 3, 2008
At the recent DIA Data Management meeting, Glaxo said it views electronic health data as valuable for both operational and strategic reasons.
There are great hopes but more than a little uncertainty around whether the pharmaceutical industry will ever have the technical means or the political latitude to mine troves of data in electronic health records. Some people point to pilot projects…
No articles available